Kinetics of macrolide action: the josamycin and erythromycin cases

Martin Lovmar1, Tanel Tenson, Måns Ehrenberg

  • 1Department of Cell and Molecular Biology, Molecular Biology Program, BMC, Box 596, Uppsala University, S-75124 Uppsala, Sweden.

Insights

Josamycin, a macrolide antibiotic, binds longer to ribosomes than erythromycin, completely halting protein synthesis. This difference in ribosome binding explains their distinct bactericidal effects, with josamycin being more potent.

Area of Science:

  • Molecular Biology
  • Microbiology
  • Biochemistry

Background:

  • Macrolide antibiotics inhibit bacterial protein synthesis by targeting the ribosome.
  • Josamycin and erythromycin are macrolides with different lactone ring sizes (16-membered vs. 14-membered).

Purpose of the Study:

  • To investigate and compare the modes of action of josamycin and erythromycin on ribosomal peptide elongation.
  • To elucidate the mechanisms underlying their differential bactericidal activities.

Main Methods:

  • Utilized a cell-free translation system with purified Escherichia coli components.
  • Measured ribosome binding, dissociation constants, and peptide bond formation kinetics.
  • Analyzed peptidyl-tRNA drop-off rates and their relationship to drug dissociation.

Main Results:

  • Josamycin exhibits a significantly longer ribosome residence time (3 h) compared to erythromycin (<2 min).
  • Josamycin has a lower dissociation constant (5.5 nM) than erythromycin (11 nM), indicating tighter binding.
  • Josamycin completely inhibits protein synthesis at saturating concentrations, while erythromycin allows for longer peptide chains.
  • Both drugs increase peptidyl-tRNA drop-off, but this is more pronounced and faster than drug dissociation for josamycin.

Conclusions:

  • Josamycin's prolonged ribosome binding and complete inhibition of protein synthesis contribute to its potent bactericidal effect.
  • Differential effects on peptide elongation and peptidyl-tRNA stability explain the varying efficacy of these macrolides.
  • Bacterial toxicity likely results from inhibited protein elongation and depleted aminoacyl-tRNA pools due to drug-induced drop-off.

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Kinetics of Drug Elimination01:17

Kinetics of Drug Elimination

Eliminating drugs from the body is a vital process that occurs through excretion or metabolism. Understanding the kinetics of drug elimination is crucial for drug development, dosage determination, and optimizing patient outcomes.
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...